Difference between revisions of "20.109(F22):Class data"
From Course Wiki
Noreen Lyell (Talk | contribs) (Created page with "<div style="padding: 10px; width: 820px; border: 5px solid #434a43;"> {{Template:20.109(F22)}}") |
Becky Meyer (Talk | contribs) (→Module 1: Genomic instability) |
||
(20 intermediate revisions by 12 users not shown) | |||
Line 1: | Line 1: | ||
<div style="padding: 10px; width: 820px; border: 5px solid #434a43;"> | <div style="padding: 10px; width: 820px; border: 5px solid #434a43;"> | ||
{{Template:20.109(F22)}} | {{Template:20.109(F22)}} | ||
+ | |||
+ | |||
+ | ==Module 1: Genomic instability== | ||
+ | |||
+ | Please find uploaded data for Mod 1 [[https://www.dropbox.com/sh/c6wtogv13iioo9b/AAD-_4X_Z6n9MOQEjPe7NVfua?dl=0 here]] | ||
+ | |||
+ | ==Module 2: Drug Discovery== | ||
+ | |||
+ | Please find uploaded data for Mod 2 [[https://www.dropbox.com/sh/5f7p1s5ip06jskc/AADdc5CByNUmLwfDfvgX4tNra?dl=0 here]] | ||
+ | |||
+ | |||
+ | Please find the DSF results for each team in the table below. Insert the Tm for FKBP12/FBKP35 in that order: | ||
+ | |||
+ | <center> | ||
+ | {| border="1" | ||
+ | |- | ||
+ | | '''Team''' | ||
+ | | '''Compound #1''' | ||
+ | | '''Compound #2''' | ||
+ | | '''Compound #3''' | ||
+ | | '''Compound #4''' | ||
+ | | '''Compound #5''' | ||
+ | |- | ||
+ | | TR Yellow | ||
+ | | DMSO; T<sub>m</sub> = [54.86/60.97] | ||
+ | | rapamycin; T<sub>m</sub> = [61.48/65.72] | ||
+ | | FK101; T<sub>m</sub> = [54.35/60.12] | ||
+ | | FK141; T<sub>m</sub> = [58.77/63.01] | ||
+ | | FK150; T<sub>m</sub> = [59.62/63.18] | ||
+ | |- | ||
+ | | TR Green | ||
+ | | DMSO; T<sub>m</sub> = [54.52 / 61.14] | ||
+ | | FK506; T<sub>m</sub> = [67.59 / 67.25] | ||
+ | | FK150; T<sub>m</sub> = [60.29 / 63.35] | ||
+ | | FK201; T<sub>m</sub> = [54.52 / 60.29] | ||
+ | | FK459; T<sub>m</sub> = [56.56 / 64.2] | ||
+ | |- | ||
+ | | TR Blue | ||
+ | | DMSO; T<sub>m</sub> = [54.20 / 61.14] | ||
+ | | rapamycin; T<sub>m</sub> = [61.31 / 66.39] | ||
+ | | FK296; T<sub>m</sub> = [58.77 / 63.34] | ||
+ | | FK401; T<sub>m</sub> = [53.52 / 61.14] | ||
+ | | FK502; T<sub>m</sub> = [59.95 / 64.19] | ||
+ | |- | ||
+ | | TR Pink | ||
+ | | DMSO; T<sub>m</sub> = [43.25, 61.13] | ||
+ | | FK506; T<sub>m</sub> = [66.22, 67.67] | ||
+ | | FK169; T<sub>m</sub> = [56.04, 62.65] | ||
+ | | FK189; T<sub>m</sub> = [57.23, 65.54] | ||
+ | | FK301; T<sub>m</sub> = [53.83, 60.96] | ||
+ | |- | ||
+ | | TR Purple | ||
+ | | DMSO; T<sub>m</sub> = [54.17, 61.13] | ||
+ | | rapamycin; T<sub>m</sub> = [61.98, 66.72] | ||
+ | | FK101; T<sub>m</sub> = [54.00, 60.79] | ||
+ | | FK169; T<sub>m</sub> = [57.57, 62.65] | ||
+ | | FK502; T<sub>m</sub> = [59.60, 64.18] | ||
+ | |- | ||
+ | | WF Yellow | ||
+ | | DMSO; T<sub>m</sub> = [55.53/61.46] | ||
+ | | FK506; T<sub>m</sub> = [50.78/67.91] | ||
+ | | FK189; T<sub>m</sub> = [60.62/67.91] | ||
+ | | FK301; T<sub>m</sub> = [56.54/61.30] | ||
+ | | FK459; T<sub>m</sub> = [60.11/51.29] | ||
+ | |- | ||
+ | | WF Green | ||
+ | | DMSO; T<sub>m</sub> = [55.53, 61.13] | ||
+ | | rapamycin; T<sub>m</sub> = [55.53, 66.22] | ||
+ | | FK150; T<sub>m</sub> = [61.13, 55.02] | ||
+ | | FK201; T<sub>m</sub> = [54.00, 52.99] | ||
+ | | FK502; T<sub>m</sub> = [53.50, 51.97] | ||
+ | |- | ||
+ | | WF Blue | ||
+ | | DMSO; T<sub>m</sub> = [55.89, 61.83] | ||
+ | | FK506; T<sub>m</sub> = [56.91, 67.77] | ||
+ | | FK141; T<sub>m</sub> = [60.47, 57.42] | ||
+ | | FK296; T<sub>m</sub> = [53.51, 64.21] | ||
+ | | FK401; T<sub>m</sub> = [54.19, 62.17] | ||
+ | |- | ||
+ | | WF Pink | ||
+ | | DMSO; T<sub>m</sub> = [56.1/49.1] | ||
+ | | rapamycin; T<sub>m</sub> = [59.5/50.8] | ||
+ | | FK101; T<sub>m</sub> = [52.8/43.8] | ||
+ | | FK169; T<sub>m</sub> = [57.2/44.7] | ||
+ | | FK459; T<sub>m</sub> = [54.9/45.0] | ||
+ | |- | ||
+ | |} | ||
+ | </center> |
Latest revision as of 17:10, 8 December 2022
Module 1: Genomic instability
Please find uploaded data for Mod 1 [here]
Module 2: Drug Discovery
Please find uploaded data for Mod 2 [here]
Please find the DSF results for each team in the table below. Insert the Tm for FKBP12/FBKP35 in that order:
Team | Compound #1 | Compound #2 | Compound #3 | Compound #4 | Compound #5 |
TR Yellow | DMSO; Tm = [54.86/60.97] | rapamycin; Tm = [61.48/65.72] | FK101; Tm = [54.35/60.12] | FK141; Tm = [58.77/63.01] | FK150; Tm = [59.62/63.18] |
TR Green | DMSO; Tm = [54.52 / 61.14] | FK506; Tm = [67.59 / 67.25] | FK150; Tm = [60.29 / 63.35] | FK201; Tm = [54.52 / 60.29] | FK459; Tm = [56.56 / 64.2] |
TR Blue | DMSO; Tm = [54.20 / 61.14] | rapamycin; Tm = [61.31 / 66.39] | FK296; Tm = [58.77 / 63.34] | FK401; Tm = [53.52 / 61.14] | FK502; Tm = [59.95 / 64.19] |
TR Pink | DMSO; Tm = [43.25, 61.13] | FK506; Tm = [66.22, 67.67] | FK169; Tm = [56.04, 62.65] | FK189; Tm = [57.23, 65.54] | FK301; Tm = [53.83, 60.96] |
TR Purple | DMSO; Tm = [54.17, 61.13] | rapamycin; Tm = [61.98, 66.72] | FK101; Tm = [54.00, 60.79] | FK169; Tm = [57.57, 62.65] | FK502; Tm = [59.60, 64.18] |
WF Yellow | DMSO; Tm = [55.53/61.46] | FK506; Tm = [50.78/67.91] | FK189; Tm = [60.62/67.91] | FK301; Tm = [56.54/61.30] | FK459; Tm = [60.11/51.29] |
WF Green | DMSO; Tm = [55.53, 61.13] | rapamycin; Tm = [55.53, 66.22] | FK150; Tm = [61.13, 55.02] | FK201; Tm = [54.00, 52.99] | FK502; Tm = [53.50, 51.97] |
WF Blue | DMSO; Tm = [55.89, 61.83] | FK506; Tm = [56.91, 67.77] | FK141; Tm = [60.47, 57.42] | FK296; Tm = [53.51, 64.21] | FK401; Tm = [54.19, 62.17] |
WF Pink | DMSO; Tm = [56.1/49.1] | rapamycin; Tm = [59.5/50.8] | FK101; Tm = [52.8/43.8] | FK169; Tm = [57.2/44.7] | FK459; Tm = [54.9/45.0] |